DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Aurinia Pharmaceuticals Q4 EPS $(0.78) Misses $(0.15) Estimate

Aurinia Pharmaceuticals (NASDAQ:AUPH) reported quarterly losses of $(0.78) per share which missed the analyst consensus estimate of $(0.15) by 420 percent. This is a 358.82 percent decrease over losses of $(0.17) per

Benzinga · 03/05/2020 21:03

Aurinia Pharmaceuticals (NASDAQ:AUPH) reported quarterly losses of $(0.78) per share which missed the analyst consensus estimate of $(0.15) by 420 percent. This is a 358.82 percent decrease over losses of $(0.17) per share from the same period last year.